Abstract
After percutaneous implantation of a cardiac occluder, a complex healing process leads to the device coverage within several months. An incomplete device coverage increases the risk of device related complications such as thrombosis or endocarditis. We aimed to assess the device coverage process of atrial septal defect (ASD) occluders in a chronic sheep model using micro-computed tomography (micro-CT). After percutaneous creation of an ASD, 8 ewes were implanted with a 16-mm Nit-Occlud ASD-R occluder (PFM medical, Cologne, Germany) and were followed for 1 month (N = 3) and 3 months (N = 5). After heart explant, the device coverage was assessed using micro-CT (resolution of 41.7 μm) and was compared to histological analysis. The micro-CT image reconstruction was performed in 2D and 3D allowing measurement of the coverage thickness and surface for each device. Macroscopic assessment of devices showed that the coverage was complete for the left-side disk in all cases. Yet incomplete coverage of the right-side disk was observed in 5 of the 8 cases. 2D and 3D micro-CT analysis allowed an accurate evaluation of device coverage of each disk and was overall well correlated to histology sections. Surface calculation from micro-CT images of the 8 cases showed that the median surface of coverage was 93±8% for the left-side disk and 55±31% for the right-side disk. The assessment of tissue reactions, including endothelialisation, after implantation of an ASD occluder can rely on in vitro micro-CT analysis. The translation to clinical practice is challenging but the potential for individual follow-up is shown, to avoid thrombotic or infective complications.
Funder
ANR
Fédération Française de Cardiologie
Publisher
Public Library of Science (PLoS)
Reference33 articles.
1. State-of-the-art atrial septal defect closure devices for congenital heart;ML O’Byrne;Interv Cardiol Clin,2019
2. Ventricular septal defect closure devices, techniques, and outcomes.;BH Morray;Interv Cardiol Clin,2019
3. Closure of the left atrial appendage using percutaneous transcatheter occlusion devices;C Gianni;J Cardiovasc Electrophysiol,2020
4. Dynamic autologous reendothelialization of small-caliber arterial extracellular matrix: a preclinical large animal study;N Dahan;Tissue Eng,2017
5. Immunohistochemical characterization of neotissues and tissue reactions to septal defect-occlusion devices.;R Foth;Circ Cardiovasc Interv,2009